TERT and melanoma: In contrast, other studies implicate that the occurrence of TERT mutations is more likely a secondary genetic event following the activation of an oncogenic signaling pathway, such as MAPK signaling in melanoma [14] or Wnt signaling in hepatocellular carcinoma [47].